Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEET

v3.3.1.900
CONSOLIDATED BALANCE SHEET - USD ($)
Feb. 29, 2016
Aug. 31, 2015
Current    
Cash and cash equivalents $ 40,224 $ 260,075
Accounts receivable 43,659 31,382
Inventory 141,436 167,986
Prepaid expenses and deposit 112,072 215,290
Total Current Assets 337,391 674,733
Patent 49,259 36,989
Property, plant and equipments 2,785 0
Total Non Current Assets 52,044 36,989
TOTAL ASSETS 389,435 711,722
Current    
Accounts payable and accrued liabilities 46,066 33,073
Due to a related party 238,221 22,052
Total Current Liabilities 284,287 55,125
TOTAL LIABILITIES 284,287 55,125
STOCKHOLDERS' EQUITY    
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 44,553,282 common shares at February 29, 2016 and 39,852,984 common shares at August 31, 2015 44,552 39,852
Additional paid-in capital 10,948,599 10,818,446
Deficit (10,728,201) (10,085,889)
Equity attributable to shareholders of the Company 264,950 772,409
Non-Controlling Interest (159,802) (115,812)
Total Stockholders' Equity 105,148 656,597
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 389,435 $ 711,722